New insights into the pathogenesis of severe corticosteroid-dependent asthma.

Abstract

Severe asthma is characterized by persistent T-cell activation, as demonstrated in both peripheral blood and bronchial mucosa. Endobronchial biopsy specimens of patients with severe, corticosteroid-dependent asthma revealed increased expression of CD25+ on mucosal T cells. Increased immunoreactivity for IL-5 further supports the evidence that the inflammatory response is orchestrated by TH2-type T cells. Peripheral blood eosinophils and total serum IgE levels were increased in the absence of allergen and despite optimal treatment. The chemokine IL-8 may also be an aggravating factor in severe asthma; as well as being a potent chemotactic and activating factor for neutrophils, it may also be chemoattractant for eosinophils. We have recently detected increased levels of free IL-8 in the peripheral blood of patients with chronic severe asthma but not in healthy control subjects or in patients with mild asthma, even after allergen challenge. In patients with severe asthma there may be an imbalance between IL-8 production and the blocking capacity of IL-8 autoantibodies. Higher levels of IL-8 complexed to IgA autoantibody and increased numbers of activated T cells were also found in patients with unstable asthma compared with patients who had severe but stable disease. We conclude that IL-8 may provide an additional marker of asthma severity and corticosteroid responsiveness.